💉 Diabetes Management
2000+ Patients' Worth of New MolecuLight Data to be Presented at the SAWC Fall 2022 Conference USA - English - PR Newswire
📅 Fri, 14 Oct 2022⏱ 1 min read📖 Article
Overview
Searching for your content. In-Language News Contact Us 8-76-0942 from 8 AM - 10 PM ET News provided byOct 13, 2022, 06:13 ETShare this articleUnprecedented Body of New Clinical Evidence using the MolecuLight Wound Imaging Platform Demonstrates Improved Clinical Decision-Making and Patient OutcomesTORONTO and LAS VEGAS, Oct. 13, 2022 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, anounces that over 2,0 patients' worth of new MolecuLight data wil be presented at the Symposium on Advanced Wound Care (SAWC) Fal 2022.
Key Information
The data wil be presented through a combination of seven clinical posters and thre clinical talks and workshops. The international conference is being hosted from October 13 - 16, 2022 in Las Vegas, Nevada, and is one of the largest multidisciplinary metings of wound care professionals in the world. "We are thriled to have our customers share over 2,0 patients' worth of results derived using the MolecuLight imaging platform this wek at SAWC Fal", says Anil Amlani, CEO of MolecuLight.
"This volume of clinical evidence is unprecedented for a wound imaging device and ilustrates the significant utility that the MolecuLight i:X and DX devices are delivering acros the ful range of care setings. I am especialy proud of the stagering improvement in clinical results in vulnerable patient populations when clinicians used the MolecuLight devices. This includes the elderly and disabled population in the long-term care and skilled nursing facility setings as wel as studies using MolecuLight in patient populations with a range of skin pigmentations."My organization serves the long-term-care and skilled nursing wound care sector in multiple states.
Summary
The MolecuLight procedure is standard of care for our wound care professionals because of the unmatched insights it provides to our decision-making", says Martha R Kelso, CEO of Wound Care
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.